advertisement
11.5.2 Topical (12)
Showing records 1 to 12
Display all abstracts in classification 11.5.2 Topical
Search within classification 11.5.2 Topical84963 Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
Bhalerao H
AAPS PharmSciTech 2020; 21: 69
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Wang N
Clinical Ophthalmology 2020; 14: 221-230
84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Dubey V
International Journal of Biological Macromolecules 2020; 152: 1224-1232
84682 Dilatation of Retinal Arterioles Induced by Topical Dorzolamide for One Week Is Impaired in Patients with Type 1 Diabetes and Mild Retinopathy
Tilma KK; Bek T
Ophthalmologica 2019; 0: 1-7
84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Mohan P
International Journal of Biological Macromolecules 2020; 152: 1224-1232
84963 Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
Koteshwara KB
AAPS PharmSciTech 2020; 21: 69
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Lu DW
Clinical Ophthalmology 2020; 14: 221-230
84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Dangi JS
International Journal of Biological Macromolecules 2020; 152: 1224-1232
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Pan Y
Clinical Ophthalmology 2020; 14: 221-230
84963 Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
Chandran S
AAPS PharmSciTech 2020; 21: 69
84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Kesavan K
International Journal of Biological Macromolecules 2020; 152: 1224-1232
85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Astakhov Y; Iureva T; Adewale A; Walker TM
Clinical Ophthalmology 2020; 14: 221-230
